HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Grows Its Mass Offering, Social-Media Prowess With NYX Buy

This article was originally published in The Rose Sheet

Executive Summary

L’Oreal’s acquisition of mass color brand NYX cosmetics could help improve the France-based firm’s performance in North America, where it has faltered of late.

You may also be interested in...



A L’Oreal First: H1 Asia Pacific Sales Equal North America Take

The France-based beauty giant is stepping up its advertising and promotional investments to target younger consumers in the region – particularly Chinese millennials increasingly receptive to luxury products – confident that growth rates won’t be leveling off any time soon.

L’Oreal May Prune Body Shop While Lauder ‘Pivots’ In New Beauty Climate

The world’s biggest beauty players are working to meet changing consumer preferences and shopping habits without forfeiting growth momentum. For L’Oreal, this means a possible sale of The Body Shop, while the Estee Lauder Companies is reinventing its retail presence and increasingly relying on smaller, flashier brands to drive growth.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel